RecallDepth
Class II Ongoing

Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 63304-089-13.

This recall is currently active, issued March 6, 2024. It was issued by Sun Pharmaceutical Industries Inc.

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
February 5, 2024
Posted
March 6, 2024
Recall Number
D-0350-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
54,960 bottles
Firm Location
Princeton, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications: Out of specification for dissolution.

Distribution

Nationwide in the U.S.

Lot / Code Info

Lot #s: MHD0606A, MHD0612A, Exp. 04/30/2024; MHD0613A, MHD0652A, MHD0657A, MHD0672A, MHD0673A, Exp. 05/31/2024; MHD0767A, MHD0768A, MHD0769A, MHD0785A, MHD0799A, MHD0800A, MHD0801A, Exp. 06/30/2024; MHD0827A, MHD0828A, MHD0875A, MHD0876A, MHD0898A, MHD0901A, Exp. 07/31/2024; MHD1081A, MHD1082A, MHD1087A Exp. 09/30/2024.

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class II Drug recalls